The Lupus Foundation of America, the national force devoted to solving the cruel mystery of lupus, announced the appointment ...

Systemic Lupus Erythematosus is an autoimmune disease affecting multiple organs. Symptoms include rashes, joint pain, anemia, ...

The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in Systemic Lupus Erythematosus) study was officially completed on February 21, 2025 ...

In this groundbreaking treatment for lupus, the immune system's primary defence cells known as T-cells were extracted and reprogrammed at ADSCC's advanced GMP laboratories, one of the few ...

B cells are central to both protective immunity and pathogenic autoimmunity. In systemic lupus erythematosus (SLE), aberrant B cell activation leads to the production of autoreactive antibodies ...

The FDA has approved Benlysta in an autoinjector that can be used at home to treat lupus nephritis, a kidney complication, in children.

Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...

my research has focused on understanding the decisions immune cells make during infection and how the breakdown of these decision-making processes cause disease. My lab’s recent findings shed light on ...

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of ...

Kezar Life Sciences' zetomipzomib trial in autoimmune hepatitis resumes as FDA lifts partial hold following a favorable safety review.